BioCentury | Dec 17, 2012
Emerging Company Profile

Alzinova: Freezing out AD

Alzinova AB is developing an Alzheimer's disease vaccine that uses an engineered beta amyloid mimic to raise an immune response against highly toxic AD-associated beta amyloid oligomers. The approach could yield a more potent protective...
Items per page:
1 - 1 of 1